4th Inflammatory Skin Diseases Summit 2021 : The Translational Revolution

Target AudienceSpecialties – Academic/Research, Dermatology, Rheumatology
Course Overview

This meeting will be addressing novel therapies for treatment of the inflammatory skin diseases affecting adults and children. This comprehensive program will be demonstrating technological/scientific/medical revolution in treating Psoriasis; Vitiligo; Atopic Dermatitis; Pemphigus; Blistering Disorders; Chronic Urticaria; Alopecia Areata etc. Program will include world-renowned scientists will be discussing evolving concepts in treating inflammatory skin diseases as well as the implications in targeted therapeutics.

The official website is www.isds2021.org.

Objectives

1. Identify and analyze new and important studies on inflammatory skin diseases
2. Apply the most current research on the diagnosis and treatment of inflammatory skin diseases, including psoriasis and eczema
3. Compare and contrast new targeted therapies for inflammatory skin diseases, and apply them to their practice
4. Recognize, manage and appropriately treat unusual presentations of inflammatory skin diseases, based on newly developed personalized approaches

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Icahn School of Medicine at Mount Sinai and The Austrian Academy of Sciences.

The Icahn School of Medicine at Mount Sinai is accredited by the ACCME to provide continuing medical education for physicians.
CreditsAMA PRA Category 1 Credits™ (1.50 hours), AMA PRA Category 1 Credits™ (5.50 hours), AMA PRA Category 1 Credits™ (5.00 hours), AMA PRA Category 1 Credits™ (5.00 hours), Non-Physician Attendance (5.00 hours), Non-Physician Attendance (5.00 hours), Non-Physician Attendance (5.50 hours), Non-Physician Attendance (1.50 hours)